Updates
** Shares of medical equipment maker GE Healthcare GEHC.O fall 13.5% to $62.25
** China launches an anti-dumping probe into imports of certain medical X-ray tubes used in CT scans from the U.S.
** China also announces export curbs on some medium and heavy rare-earth metals, including gadolinium, which is used in MRI scans
** China, which contributed ~12% of GEHC's revenue in 2024, is one of the key markets where majority of products sold are imaging equipment
** "The risk is that any ruling from the (Chinese) ministry could impact tender processes and sales within a key market," BTIG analysts say
** "It is clear that the Chinese government is taking steps to prop up a historically lagging medical device industry, and will likely take more proactive measures in the future to favor local Chinese MedTech vs foreign competition" - J.P.Morgan analysts
** An anti-dumping investigation examines whether goods imported into a country are being sold at prices lower than their domestic market prices
** Including session moves, GEHC down ~20% vs ~1% decline in S&P Healthcare Equipment .SPLRCMED YTD
(Reporting by Bhanvi Satija and Mariam Sunny in Bengaluru)
((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。